Seizure Disorders Clinical Trials

A listing of Seizure Disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Sage Therapeutics
Birmingham Alabama 35233

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Birmingham Alabama 35233

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Mobile Alabama 36617

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Arizona

Sage Therapeutics
Phoenix Arizona 85006

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Phoenix Arizona 85013

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Arkansas

Sage Therapeutics
Little Rock Arkansas 72202

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

California

Sage Therapeutics
Fresno California 93701

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Loma Linda California 92354

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Roseville California 95661

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Sacramento California 95317

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Connecticut

Sage Therapeutics
New Haven Connecticut 06510

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

District of Columbia

Sage Therapeutics
Washington District of Columbia 20010

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Florida

Sage Therapeutics
Gainesville Florida 32610

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Jacksonville Florida 32209

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Miami Florida 33155

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Orlando Florida 32803

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Sarasota Florida 34239

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Weston Florida 33331

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Georgia

Sage Therapeutics
Atlanta Georgia 30342

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Atlanta Georgia 30303

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Atlanta Georgia 30322

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Atlanta Georgia 30322

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Idaho

Sage Therapeutics
Boise Idaho 83706

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Illinois

Sage Therapeutics
Chicago Illinois 60611

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Chicago Illinois 60611

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Chicago Illinois 60612

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Peoria Illinois 61637

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Springfield Illinois 62702

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Urbana Illinois 61801

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Iowa

Sage Therapeutics
Iowa City Iowa 52242

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Kansas

Sage Therapeutics
Wichita Kansas 67214

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Kentucky

Sage Therapeutics
Lexington Kentucky 40503

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

University of Kentucky Chandler Medical Center
Lexington Kentucky 40536

ESETT Established Status Epilepticus Treatment Trial (ESETT)

University of Kentucky Chandler Medical Center
Lexington Kentucky 40536

Still having seizures despite taking antiepileptic medication?

Sage Therapeutics
Louisville Kentucky 40202

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Louisiana

Sage Therapeutics
Baton Rouge Louisiana 70808

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
New Orleans Louisiana 70115

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Maine

Sage Therapeutics
Portland Maine 04102

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Maryland

Sage Therapeutics
Baltimore Maryland 21215

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Baltimore Maryland 21201

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Massachusetts

Sage Therapeutics
Boston Massachusetts 02215

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Boston Massachusetts 02111

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Boston Massachusetts 02114

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Boston Massachusetts 02115

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Newton Massachusetts 02462

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Michigan

Sage Therapeutics
Ann Arbor Michigan 48109

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Detroit Michigan 48202

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Detroit Michigan 48201

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
East Lansing Michigan 48824

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Grand Rapids Michigan 49503

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus